There have been many positives from the biotech sector this year. Mike Perrone discusses 2022 biotech in review. He looks at popular biotech stocks such as Amgen (AMGN), Biogen (BIIB), Gilead Sciences (GILD), Moderna (MRNA), Pfizer (PFE), Novavax (NAX), Johnson & Johnson (JNJ), Abbott (ABT), and Merck (MRK). He then goes over subsectors in biotech to watch in 2023. he also talks about the impact of successful Alzheimer's drug trials, as well as how the inflation reduction act affects biotech stocks. Tune in to find out more about the stock market today.